Can the electrophysiological action of rosiglitazone explain its cardiac side effects? - Wikidata - wikimedia - TriplyDB

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

http://www.wikidata.org/entity/Q36032128

about

Drug-induced mitochondrial dysfunction and cardiotoxicity.

P2860

Q36339445-590EFC81-204D-4912-A954-268B51475E20

P2860

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

http://www.wikidata.org/entity/Q36032128

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@ast

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@en

type

label

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@ast

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@en

prefLabel

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@ast

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@en

P1433

Q36032128-503306D2-17FF-4297-A5E7-5998007F61CA

P1476

Q36032128-DE6E465F-4B63-4E4A-BC9C-F193C3A2D0EC

P2093

Q36032128-10920A50-3002-42AD-A1C1-CCCD2DB05EF4

Q36032128-9FD1AF4E-CC9B-45CD-8699-AD3726AFD8F9

Q36032128-B5009B1F-D61D-4678-AE96-AAACE35E59C4

Q36032128-C939AE94-06C4-42AE-A6EF-F47851DD63E4

Q36032128-CFC80CDD-67B2-464D-882C-FCDDA034DF15

P2860

Q36032128-006A21E8-9553-45DB-9EEC-6B16ECC02CE1

Q36032128-00A2A5B8-F495-4C8D-B8BD-A313B7BD4677

Q36032128-067C6253-AB09-4305-9D91-415C9A538D69

Q36032128-070BC41E-C268-4206-A47D-13DA7AF73148

Q36032128-135AFEA2-1BC3-4B15-978B-6DE804FE9439

Q36032128-1630A991-1D5E-464C-96F8-79644701E32A

Q36032128-171456E8-BCC7-4876-A0DE-887E1CA785C8

Q36032128-17A06A69-6B38-4ACC-B2B1-CB847BE675CB

Q36032128-18BBEE8D-026E-4F28-970E-D7B4BF5C09C9

Q36032128-1CAA815B-56CB-498C-8759-4DB9AD7C53CE

P304

Q36032128-5D032137-9FF3-4217-81DA-DEDEF598E523

P31

Q36032128-BFD420A1-9054-4DC4-BA1C-1E7E0F1C0E4C

P356

Q36032128-E13687C6-E77A-43F3-ABBB-EE17C0B0565F

P433

Q36032128-B334B31A-1185-41B0-ABEB-F45136CA31D9

P478

Q36032128-6BBAD1E2-B30B-4A53-BF2B-F5DC4FC0A30D

P50

Q36032128-438A61F7-02D8-4B52-9285-EA3866F64B9E

P577

Q36032128-4A6FB6F4-0C27-40F9-B22E-F6457571C762

P698

Q36032128-7F30D82E-0F08-4ECF-988D-43353F541F2D

P932

Q36032128-3C18B7F1-DBB5-4667-BBD2-49E7D9E99962

P356

092986711796642364

P1433

Current Medicinal Chemistry

P1476

Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

@en

P2093

A Szebeni

http://www.w3.org/2001/XMLSchema#string

J Simkó

http://www.w3.org/2001/XMLSchema#string

N Szentandrássy

http://www.w3.org/2001/XMLSchema#string

P P Nánási

http://www.w3.org/2001/XMLSchema#string

V Kecskeméti

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.

Thiazolidinediones: a new class of antidiabetic drugs.

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.

Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

Thiazolidinediones.

P304

3720-3728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/092986711796642364

http://www.w3.org/2001/XMLSchema#string

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21774756

http://www.w3.org/2001/XMLSchema#string

P932

3375180

http://www.w3.org/2001/XMLSchema#string